SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sandu Pharmaceuticals shines on inking MoU with Bach Ma Van Xuan Pharmaceuticals

12 Dec 2022 Evaluate

Sandu Pharmaceuticals is currently trading at Rs. 65.85, up by 2.50 points or 3.95% from its previous closing of Rs. 63.35 on the BSE.

The scrip opened at Rs. 66.55 and has touched a high and low of Rs. 66.55 and Rs. 64.55 respectively. So far 1582 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 86.00 on 26-Apr-2022 and a 52 week low of Rs. 43.35 on 21-Dec-2021.

Last one week high and low of the scrip stood at Rs. 67.50 and Rs. 62.50 respectively. The current market cap of the company is Rs. 55.82 crore.

The promoters holding in the company stood at 49.47%, while Institutions and Non-Institutions held 0.01% and 50.52% respectively.

Sandu Pharmaceuticals has entered into Memorandum of understanding (MoU) with Bach Ma Van Xuan Pharmaceuticals. The purpose of this MOU is to further business relationship and to broaden the scope between two Companies in Vietnam and India. Specifically Bach Ma Van Xuan Company brings Sandu’s traditional medicine and cosmetic products to distribution in Vietnam.

Sandu Pharmaceuticals, popularly called by people Sandu Ayurveda, is one of the renewed brands when it's come to Ayurvedic health care Products or Medicines.

Sandu Pharmaceutical Share Price

38.80 0.35 (0.91%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×